Analysts review Repare Therapeutics Inc’s rating

Repare Therapeutics Inc’s recently made public that its EVP, CHIEF MEDICAL OFFICER Koehler Maria unloaded Company’s shares for reported $4099.0 on Mar 12 ’25. In the deal valued at $1.14 per share,3,596 shares were sold. As a result of this transaction, Koehler Maria now holds 227,813 shares worth roughly $0.33 million.

Then, Zinda Michael sold 5,611 shares, generating $6,397 in total proceeds. Upon selling the shares at $1.14, the EVP, CHIEF SCIENTIFIC OFFICER now owns 80,297 shares.

Before that, Forte Steve sold 6,884 shares. Repare Therapeutics Inc shares valued at $7,848 were divested by the EVP, CHIEF FINANCIAL OFFICER at a price of $1.14 per share. As a result of the transaction, Forte Steve now holds 54,786 shares, worth roughly $78343.98.

Stifel upgraded its Repare Therapeutics Inc [RPTX] rating to a Buy from a a Hold in a research note published on June 09, 2023; the price target was increased to $16 from $11. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early February from “an Overweight” to “an Equal-weight”. CapitalOne began covering RPTX with “an Overweight” recommendation on January 06, 2023. Stifel revised its rating on April 12, 2022. It rated RPTX as “a Hold” which previously was an “a Buy”.

Price Performance Review of RPTX

On Tuesday, Repare Therapeutics Inc [NASDAQ:RPTX] saw its stock fall -8.92% to $1.43. Over the last five days, the stock has lost -6.54%. Repare Therapeutics Inc shares have fallen nearly -59.72% since the year began. Nevertheless, the stocks have risen 9.16% over the past one year. While a 52-week high of $4.29 was reached on 07/10/25, a 52-week low of $0.89 was recorded on 04/14/25.

Levels Of Support And Resistance For RPTX Stock

The 24-hour chart illustrates a support level at 1.3500, which if violated will result in even more drops to 1.2700. On the upside, there is a resistance level at 1.5300. A further resistance level may holdings at 1.6300.

How much short interest is there in Repare Therapeutics Inc?

A steep rise in short interest was recorded in Repare Therapeutics Inc stocks on 2025-06-13, growing by 38409.0 shares to a total of 0.59 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.56 million shares. There was a rise of 6.47%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.